162 results
Page 2 of 9
S-4/A
18ln2ya4kn52hq
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-10.1
ukj rif0s
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
EX-99.1
ad7gj61lwb8vyz7oa
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
wzvmwd30i7rnl b1z
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
5bntw0dxhyjgr 28qt
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
skpj6m4
20 Dec 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
0cjab41
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
4nb7oz2y7 21qel1a
28 Apr 22
Prospectus supplement for primary offering
8:09am